These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1084825)

  • 1. Intestinal blood loss after a new anti-inflammatory drug, sulindac.
    Cohen A
    Clin Pharmacol Ther; 1976 Aug; 20(2):238-40. PubMed ID: 1084825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of sulindac and aspirin in rheumatoid arthritis.
    Reynolds PM; Rhymer AR; MacLeod MM; Buchanan WW
    Curr Med Res Opin; 1977; 4(7):485-91. PubMed ID: 321183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of chronic polyarthritis with Sulindac].
    Vetter G; Picha B
    MMW Munch Med Wochenschr; 1977 Oct; 119(42):1369-70. PubMed ID: 412071
    [No Abstract]   [Full Text] [Related]  

  • 4. Gastric bleeding and gastric secretion with sulindac and naproxen.
    Hunt JN; Smith JL; Jiang CL
    Dig Dis Sci; 1983 Feb; 28(2):169-73. PubMed ID: 6600677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of fecal blood loss after use of aspirin and suprofen.
    Arnold JD; Berger AE
    Pharmacology; 1983; 27 Suppl 1():14-22. PubMed ID: 6606810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sulindac: Clinical test of a new antiinflammatory agent in rheumatoid arthritis (author's transl)].
    Fasching U; Eberl R
    Wien Klin Wochenschr Suppl; 1976; 59():1-10. PubMed ID: 136815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiochromium (chromium-51) evaluation of gastrointestinal blood loss associated with placebo, aspirin, and nabumetone.
    Lussier A; LeBel E
    Am J Med; 1987 Oct; 83(4B):15-8. PubMed ID: 3500642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal blood loss in patients receiving acetylsalicylic acid or diftalone, a new antiinflammatory drug: a comparative evaluation.
    Marchetti M; Vignati E; Nicolis FB
    Curr Ther Res Clin Exp; 1974 Jul; 16(7):742-7. PubMed ID: 4210464
    [No Abstract]   [Full Text] [Related]  

  • 9. A multicenter trial of sulindac in osteoarthritis of the hip.
    Calabro JJ; Andelman SY; Caldwell JR; Gerber RC; Hamaty D; Kaplan H; Maltz BA; Parsons JL; Saville P; Tretbar HC; Ward JR
    Clin Pharmacol Ther; 1977 Sep; 22(3):358-63. PubMed ID: 330080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulindac. Trials of a new anti-inflammatory drug.
    Huskisson EC; Scott J
    Ann Rheum Dis; 1978 Feb; 37(1):89-92. PubMed ID: 343728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal microbleeding in normal subjects receiving acetylsalicylic acid, placebo, and R-803, a new antiinflammatory agent, in a design balanced for residual effects.
    Arsenault A; LeBel E; Lussier A
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):473-80. PubMed ID: 1086311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled endoscopic study comparing the toxic effects of sulindac, naproxen, aspirin, and placebo on the gastric mucosa of health volunteers.
    Lanza FL; Nelson RS; Rack MF
    J Clin Pharmacol; 1984; 24(2-3):89-95. PubMed ID: 6715565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occult gastrointestinal bleeding due to aspirin: comparison of two compounds.
    Rossouw JE; Clarke M; Davis M; Williams R
    Rheumatol Rehabil; 1976 Feb; 15(1):31-4. PubMed ID: 1082620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of Voltaren on the gastrointestinal excretion of blood (author's transl)].
    Uthgenannt H; Timm H
    MMW Munch Med Wochenschr; 1975 Dec; 117(50):1987-90. PubMed ID: 814415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal blood loss induced by bromfenac sodium, aspirin, and placebo.
    Cohen A
    Clin Ther; 1995; 17(6):1110-7. PubMed ID: 8750402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal microbleeding: comparisons between benoxaprofen and other nonsteroidal antiinflammatory agents.
    Ridolfo AS; Crabtree RE; Johnson DW; Rockhold FW
    J Rheumatol Suppl; 1980; 6():36-47. PubMed ID: 6993671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of aspirin and enteric-coated aspirin on loss of chromium 51-labeled erythrocytes from the gastrointestinal tract.
    Robbins DC; Schwartz RS; Kutny K; Vallejo G; Horton ES; Cotter JM
    Clin Ther; 1984; 6(4):461-6. PubMed ID: 6331883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal blood loss and plasma salicylate study of salicylsalicylic acid and aspirin.
    Cohen A
    J Clin Pharmacol; 1979 Apr; 19(4):242-7. PubMed ID: 312297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal blood loss caused by tolmetin, aspirin, and indomethacin.
    Beirne JA; Bianchine JR; Johnson PC; Wortham GF
    Clin Pharmacol Ther; 1974 Nov; 16(5 Part 1):821-5. PubMed ID: 4547691
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative study of gastrointestinal microbleeding caused by aspirin, fenbufen, and placebo.
    Lussier A; Tétreault L; Lebel E
    Am J Med; 1983 Oct; 75(4B):80-3. PubMed ID: 6605682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.